How the immune system changes over time in chronic hepatitis B
Part of Digestive system, Infections clinical trials.
This study tracks how the immune system works in people with chronic hepatitis B who haven't taken antiviral medication in the last 6 months. It aims to understand the natural history of the infection without treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 80 years old
- You have been diagnosed with chronic hepatitis B (a long-term liver infection from the hepatitis B virus)
- You have not taken any antiviral medication (like pills or shots) for hepatitis B in the last 6 months
- You do not have other serious liver diseases or active infections like hepatitis C or HIV
- You do not have certain immune system disorders (like hyperthyroidism) or blood clotting problems (like diabetes or low platelets)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with HIV who also have a past hepatitis B infection (without active virus) to see if switching to long-acting HIV medications causes the hepatitis B to come back. It may help find safer ways to switch treatments.
This study looks at how the immune system changes over time in people with chronic hepatitis B. It will help doctors better understand the stages of the disease to guide treatment decisions.
This study looks at how a specific protein (ANKRD11) affects immune cells in people with chronic hepatitis B. By understanding this, researchers hope to find ways to help your immune system fight the virus better.
This “real-life” study follows people with chronic hepatitis B to better understand their health over time. It may help researchers learn which factors affect outcomes in everyday care.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This study looks at people with hepatitis B or C infections that have lasted more than 6 months. It aims to better understand long-term management and how treatments may help over time.
Hear when a new HBV (Hepatitis B Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.